Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2018 Sep 4:2018:bcr2017222947.
doi: 10.1136/bcr-2017-222947.

First report of concomitant pheochromocytoma and duodenal neuroendocrine tumour in a sporadic multiple endocrine neoplasia type 1

Affiliations
Case Reports

First report of concomitant pheochromocytoma and duodenal neuroendocrine tumour in a sporadic multiple endocrine neoplasia type 1

Banafsheh Motazedi et al. BMJ Case Rep. .

Abstract

A 77-year-old woman was diagnosed with pheochromocytoma followed by adrenalectomy at age 57. Hyperparathyroidism without osteoprosis was diagnosed at age 58. At age 75, Dual Energy X-ray Absoptiometry (DEXA) revealed osteoporosis and sestamibi scan showed a left parathyroid adenoma. Criteria for parathyroidectomy were met, and she underwent parathyroidectomy. Furthermore, she presented with haematochezia at age 75. An abdominal CT demonstrated a mass in the second portion of the duodenum. Additionally, octreoscan revealed somatostatin receptor positive tissue in the duodenum and Gallium 68 dotatate scan also showed a well-differentiated duodenal neuroendocrine tumour (NET). Genetic testing for MEN1, MEN2 and MEN4 was negative. Diagnosis of sporadic MEN1 syndrome was made. The patient underwent resection of the duodenal NET at age 76. She is in good health 21 years after her first presentation of MEN1. In summary, we present the first sporadic case of MEN1 with concomitant pheochromocytoma and duodenal NET which occurred 20 years apart.

Keywords: adrenal disorders; calcium and bone; endocrine cancer; neuroendocrinology; neurogastroenterology.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
(A) White arrow demonstrates the duodenal neuroendocrine tumour (NET) in abdominal CT scan with contrast. (B) White arrow demonstrates the uptake of gallium 68 by duodenal NET in GA-68 dotatate scan. (C) White arrow depicts microinvasion of gall bladder by the duodenal NET on abdominal CT scan with contrast. (D) White arrows demonstrate metastasis to peripancreatic lymph nodes on abdominal CT scan with contrast.

References

    1. Chandrasekharappa SC, Guru SC, Manickam P, et al. . Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science 1997;276:404–7. 10.1126/science.276.5311.404 - DOI - PubMed
    1. Kouvaraki MA, Lee JE, Shapiro SE, et al. . Genotype-phenotype analysis in multiple endocrine neoplasia type 1. Arch Surg 2002;137:641–7. 10.1001/archsurg.137.6.641 - DOI - PubMed
    1. Thakker RV. Multiple endocrine neoplasia type 1 (MEN1). Best Pract Res Clin Endocrinol Metab 2010;24:355–70. 10.1016/j.beem.2010.07.003 - DOI - PubMed
    1. Romei C, Pardi E, Cetani F, et al. . Genetic and clinical features of multiple endocrine neoplasia types 1 and 2. J Oncol 2012;2012:1–15. 10.1155/2012/705036 - DOI - PMC - PubMed
    1. Lairmore TC, Piersall LD, DeBenedetti MK, et al. . Clinical genetic testing and early surgical intervention in patients with multiple endocrine neoplasia type 1 (MEN 1). Ann Surg 2004;239:637–47. 10.1097/01.sla.0000124383.98416.8d - DOI - PMC - PubMed

Publication types

MeSH terms